MGI Tech Singapore Pte, Ltd. ('MGI'), a company committed to building core tools and technology to lead life science, recently entered a research partnership with National Cancer Centre Singapore ('NCCS') to facilitate comprehensive, multi-dimensional genomic profiling of Asian-prevalent cancers using MGI's core DNBSEQ™ technology.
From MGISep 18 2023 SINGAPORE, Sept. 15, 2023 /PRNewswire/ -- MGI Tech Singapore Pte, Ltd. , a company committed to building core tools and technology to lead life science, recently entered a research partnership with National Cancer Centre Singapore to facilitate comprehensive, multi-dimensional genomic profiling of Asian-prevalent cancers using MGI's core DNBSEQ™ technology.
Under the partnership, MGI's DNBSEQ-G400 sequencer has been set up at NCCS' Cancer Discovery Hub for running RNA-seq samples. The versatile benchtop sequencer is built with a dual Flow Cell system that can flexibly support a variety of different sequencing modes. Thanks to optimized optical and biomedical systems, manual operation for whole genome sequencing is shortened to under 30 minutes from sample to report.
"Combining CDH's expertise in multi-omics molecular diagnostic and research with MGI's state-of-the-art high-throughput sequencing technologies, this collaboration will not only shed light on the mechanics and potential development of Asian-prevalent cancers, but also inform better ways of preventing, diagnosing and treating these cancers," said Dr. Jason Chan, Director of NCCS Cancer Discovery Hub.
Beyond this partnership, NCCS also intended to join the DCS Lab Initiative, MGI's first program aimed at facilitating large-scale leading multi-omics laboratories with MGI's products. Under the initiative, MGI will offer DNA sequencing, Cell omics and Spatial omics products combined with DNBSEQ technology for a wide array of applications to NCCS, which will help spurring critical oncology research contributing to better prevention, diagnostics, and treatment outcomes.
Belgique Dernières Nouvelles, Belgique Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
'We need to normalise conversations about cancer and life after cancer'Mum-of-three Tracey is on a mission to help improve conversations about cancer after being treated for womb cancer
Lire la suite »
MGI's Innovative Technologies Is Enabling Sequencing of First Plant Species in The African BioGenome ProjectMGI, a company committed to building core tools and technology to lead life science, is delighted to support The African BioGenome Project (AfricaBP), launched in 2021, in sequencing of the project's first plant species based on MGI's DNBSEQ-G400* versatile benchtop sequencer and single-tube long fragment read (stLFR) technology.
Lire la suite »
MGI Introduces New Chapter in Smart Laboratory Management with Official Opening of αLab in HKSTPMGI, a company committed to building core tools and technology to lead life science, today announced the official opening of αLab in the Hong Kong Science & Technology Parks ('HKSTP'), the city's largest R&D base and one of the most important incubators.
Lire la suite »
Co Antrim mum diagnosed with cancer after thinking lump could be ingrown hair'Anyone who knows Stef will know how fiercely strong and independent she is'
Lire la suite »
Lung cancer symptom in the arm or shoulder that should never be ignoredThere are a number of lesser-known lung cancer warning signs including pins and needle like pain that impacts the arm, shoulder or chest.
Lire la suite »